Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Covington
Fish and Richardson
McKinsey
US Army
Dow
Mallinckrodt
Medtronic
Cerilliant

Generated: August 18, 2018

DrugPatentWatch Database Preview

HEPATAMINE 8% Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Hepatamine 8% patents expire, and what generic alternatives are available?

Hepatamine 8% is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in HEPATAMINE 8% is amino acids. There are three hundred and forty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.

Summary for HEPATAMINE 8%
Drug patent expirations by year for HEPATAMINE 8%
Pharmacology for HEPATAMINE 8%
Ingredient-typeAmino Acids
Drug ClassAmino Acid

US Patents and Regulatory Information for HEPATAMINE 8%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun HEPATAMINE 8% amino acids INJECTABLE;INJECTION 018676-001 Aug 3, 1982 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for HEPATAMINE 8%

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
B Braun HEPATAMINE 8% amino acids INJECTABLE;INJECTION 018676-001 Aug 3, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Moodys
Queensland Health
US Army
Citi
Baxter
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.